At last, a weight neutral insulin? (Q80442190)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15306837%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

At last, a weight neutral insulin? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15306837%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

2

H Häring

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15306837%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

A Fritsche

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15306837%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 September 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15306837%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

28 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15306837%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

S41-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15306837%20AND%20SRC:MED&resulttype=core&format=json

Tests of glycemia in diabetes

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Weight gain associated with intensive therapy in the diabetes control and complications trial. The DCCT Research Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Can clinical factors estimate insulin resistance in type 1 diabetes?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Is continued weight gain inevitable in type 2 diabetes mellitus?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Importance of Weight Management in Type 2 Diabetes: Review with Meta-analysis of Clinical Studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Effect of BMI, insulin dose and number of injections on glycaemic control in insulin-using diabetic patients. Studygroup Diabetes Rijnmond (SDR)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

When oral agents fail: practical barriers to starting insulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Intentional weight loss and death in overweight and obese U.S. adults 35 years of age and older

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Obesity stigmatization and coping: relation to mental health symptoms, body image, and self-esteem

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Is dieting good for you?: Prevalence, duration and associated weight and behaviour changes for specific weight loss strategies over four years in US adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Treatment of obesity hypertension and diabetes syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Weight gain associated with improved glycemic control in population-based sample of subjects with type I diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

The Mechanism of Protraction of Insulin Detemir, a Long-Acting, Acylated Analog of Human Insulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Central nervous system control of food intake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Intensive insulin therapy and weight gain in IDDM.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

The effects of intensive glycaemic control on body composition in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Barriers to good glycaemic control: the patient's perspective

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802749

7 January 2021

Identifiers

DOI

10.1038/SJ.IJO.0802749

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15306837%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference